CorMedix Therapeutics (NASDAQ: CRMD) announced that its board of directors approved a share repurchase program authorizing the company to buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE